Trial Profile
A Single-Centre, Single Dose, Randomized,Open Label, Exploratory, 5-Way Crossover Study Evaluating the Pharmakokinetic Profiles of Various Egalet Hydrocodone Formulations In Healthy Volunteers Under Fasting Conditions.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Hydrocodone (Primary) ; Hydrocodone/paracetamol
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Egalet; Zyla Life Sciences
- 18 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Dec 2008 New trial record.